What sunscreen is safe for babies, and from what age?

Under 6 months: shade and clothing come first

Under six months, the bottom line is to keep your baby out of direct sun and rely on shade and clothing. The FDA says sunscreen is not recommended for infants under six months and warns that babies face a higher risk of side effects such as rash [3].

The AAD says sunscreen should be avoided where possible, but a minimal amount of physical sunscreen on small exposed areas is acceptable if shade and clothing are unavailable [2]. The NHS takes a similar line, suggesting sunscreen only on small areas such as the face and hands when protective clothing or shade isn't an option [1]. Sources differ slightly on that fallback, so treat it as a last resort, not a routine step.

Why the caution? Infant skin is less mature and more prone to percutaneous absorption, which is the main rationale for minimizing use in this age group [4]. A StatPearls summary attributes the caution to an immature skin barrier and recommends gentle, non-irritating products with low sensitizing potential [6].

From 6 months: SPF 30, broad-spectrum, water-resistant

From six months, the bottom line is an SPF of 30 or higher with broad-spectrum and water-resistant claims. The AAD says SPF 30 blocks about 97% of UVB, compared with about 93% for SPF 15 [7][8]. The Skin Cancer Foundation lists SPF 15 as its minimum [9], so SPF 30 is the stricter and more useful target.

Why mineral filters are the usual pick

The bottom line is that mineral filters are the most commonly recommended option for babies. The AAD notes that zinc oxide or titanium dioxide, or products made for infants, may cause less irritation [2]. Mineral filters also sit on the skin's surface rather than being absorbed the way many chemical filters are.

In a recent JAAD cross-sectional analysis of 94 top-selling Amazon baby sunscreens, 76.6% were mineral-based and 92.6% were water-resistant, and all were labeled SPF 30+ and broad-spectrum [10]. A 2023 analysis of 27 products marketed to babies found 85% used only physical filters, 11% only chemical filters, and 3.7% both. Zinc oxide was the sole filter in 52% of them [11].

Oxybenzone: what is real and what is hype

The bottom line is that oxybenzone is the ingredient to avoid, though the reasons are about absorption and regulation rather than proof of harm. None of the 'baby' products in the 2023 analysis contained oxybenzone, while it appeared more often in 'children,' 'kids,' and 'sports' products [11][13]. The AAP advises avoiding it where possible because of concerns about mild hormonal effects, as reported in that analysis [13].

The FDA's proposed order says the agency lacks sufficient data to classify oxybenzone at up to 6% as generally recognized as safe and effective. It cites skin absorption and detection in breast milk, urine, and blood, and it applies to all ages, not only infants [16]. In an FDA-sponsored maximal-use adult trial, plasma levels reached up to 258.1 ng/mL after lotion, far above the 0.5 ng/mL threshold for toxicology testing [17][18]. Those were adult studies, so they show absorption but do not measure infant exposure.

What the evidence does and does not show

The bottom line is that the infant evidence is thin. We found no randomized trial or systematic review measuring sunscreen safety or absorption in infants under six months, so the under-6-month rule rests on expert consensus and skin physiology.

The most relevant trial is a randomized, double-blind crossover study at Rady Children's Hospital with 30 infants and children aged 6 months to 4 years. Each product was used for two weeks, with dermatologists assessing tolerance every two weeks [14]. The authors describe the micronized inorganic filters as chemically inert and non-penetrating [15]. The abstract we retrieved does not give final tolerability or efficacy numbers, and the study dates to around 2009, so we could not confirm its results. For more on picking products, see our sunscreen guide.

• We did not retrieve the AAP's own policy statement, so its position is cited only through secondary sources.
• The main infant trial is small, and its outcome numbers remain unverified.
• Official sites such as the NHS and FDA, not product marketing, are the right place to check current guidance [1][3].